Xiidra is a lymphocyte function-associated antigen-1 (LFA-1) antagonist approved for treating both the signs and symptoms of dry eye disease. Because it targets specific inflammatory pathways, it is .

Ships medicine that arrives in foreign-language packaging or has no expiration date.

The Digital Landscape of Xiidra: Navigating Safety, Cost, and Access